Artificial Intelligence

Hippocratic AI

Medium1/1 relationships sourcedProfile verified Aug 16, 2026

30-Second Executive Brief

Executive Assessment

Hippocratic AI functions as a regional institution within Artificial Intelligence, backed by 80% sourcing coverage, with a stable competitive position.

  • Maintains 1 mapped relationship across the graph
  • 80% sourcing coverage across sourced relationships
  • Tracked as regional institution within the Artificial Intelligence category

Executive Snapshot

Strategic Role
Regional Institution
Sourcing Coverage
80%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
Moderate
Strategic Momentum
Insufficient Data

Coverage

Mapped Relationships
1
Technology Domains
3

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Continued expansion across health-system, payor and life-sciences partnerships as generative healthcare agent adoption grows.

Top Risks

Patient-facing healthcare AI carries elevated regulatory and liability scrutiny even with a non-diagnostic design constraint.

Critical Dependencies

Continue to Dependency Graph ↓

A healthcare AI startup building safe, non-diagnostic generative AI agents for patient-facing care (the agents are explicitly barred from prescribing or diagnosing), backed by Andreessen Horowitz, General Catalyst, Kleiner Perkins and NVIDIA's NVentures following a direct technical collaboration on healthcare LLMs. Hippocratic AI closed a $126 million Series C in November 2025 at a $3.5 billion valuation, bringing total funding to $404 million, and has since expanded across new health-system, payor, public-sector and life-sciences partnerships.

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

1 source

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding Hippocratic AI — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

The Story So Far

Jan 2023: FoundedSep 2024: NVentures investmentNov 2025: $126M Series C at $3.5B valuationNov 2025: Hippocratic AI raises $126M Series C at $3.5B valuation

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

Hippocratic AI's Timeline

A sourced, dated history of Hippocratic AI's key moments — founding to present.

  1. Jan 2023 · Founded

    Hippocratic AI was founded to build non-diagnostic, patient-facing generative AI healthcare agents.

  2. Sep 2024 · NVentures investment

    NVIDIA's NVentures invested in Hippocratic AI following technical collaboration on healthcare LLMs.

  3. Nov 2025 · $126M Series C at $3.5B valuation

    Hippocratic AI raised $126 million at a $3.5 billion valuation, led by Avenir Growth, bringing total funding to $404 million.